| [1] |
沈艳，郭筱兰. 早期乳腺癌的影像学筛查现状与进展[J/CD]. 中华乳腺病杂志(电子版), 2017, 11(2): 114-116.
|
| [2] |
陈君，王小飞，张蕾，等. 钼靶、超声和MRI对乳腺肿块诊断价值的Meta分析[J]. 实用放射学杂志，2016, 32(4): 531-535.
|
| [3] |
Spak DA, Plaxco JS, Santiago L, et al. BI-RADS fifth edition: A summary of changes[J]. Diagn Interv Imaging，2017，98(3)：179-190.
|
| [4] |
King V, Gu Y, Kaplan JB, et al. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI[J]. Eur Radiol，2012，22(12)：2641-2647.
|
| [5] |
Telegrafo M, Rella L, Stabile Ianora AA，et al. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging[J]. Diagn Interv Imaging，2016，97(3)：315-320.
|
| [6] |
DeMartini WB, Liu F, Peacock S, et al. Background parenchymal enhancement on breast MRI: impact on diagnostic performance[J]. AJR Am J Roentgenol，2012，198(4)：W373-380.
|
| [7] |
Preibsch H, Wanner L, Bahrs SD, et al. Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response[J]. Eur Radiol，2016，26(6)：1590-1596.
|
| [8] |
Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice[J]. Radiology，2007，244(2)：356-378.
|
| [9] |
Giess CS, Yeh ED, Raza S, et al. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation[J]. Radiographics，2014，34(1)：234-247.
|
| [10] |
Kang SS, Ko EY, Han BK, et al. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition[J]. J Magn Reson Imaging，2014，39(3)：526-534.
|
| [11] |
Taron J, Fleischer S, Preibsch H，et al. Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis？[J]. Eur Radiol，2019，29(3)：1187-1193.
|
| [12] |
Kim YJ, Kim SH, Choi BG，et al. Impact of radiotherapy on background parenchymal enhancement in breast magnetic resonance imaging[J]. Asian Pac J Cancer Prev，2014，15(7)：2939-2943.
|
| [13] |
King V, Kaplan J, Pike MC, et. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging[J]. Breast J，2012，18(6)：527-534.
|
| [14] |
King V, Goldfarb SB, Brooks JD, et al. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging[J]. Radiology，2012，264(3)：670-678.
|
| [15] |
Price ER, Brooks JD, Watson EJ, et al. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue[J]. Eur Radiol，2014，24(1)：162-168.
|
| [16] |
Zeng L, Lo G, Moshonov H, et al. Breast background parenchymal enhancement on screening magnetic resonance imaging in women who received chest radiotherapy for childhood Hodgkin’s lymphoma[J]. Acad Radiol，2016，23(2)：168-175.
|
| [17] |
Rao AA, Feneis J, Lalonde C，et al. A pictorial review of changes in the BI-RADS fifth edition[J]. Radiographics，2016，36(3)：623-639.
|
| [18] |
Hegenscheid K, Schmidt CO, Seipel R, et al. Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography--influence of anthropometric measures and menopausal status[J]. Radiology，2013，266(1)：72-80.
|
| [19] |
Ha R, Mema E, Guo X，et al. Three-dimensional auantitative validation of breast magnetic resonance imaging background parenchymal enhancement assessments[J]. Curr Probl Diagn Radiol，2016，45(5)：297-303.
|
| [20] |
Lam DL, Hippe DS, Kitsch AE, et al. Assessment of quantitative magnetic resonance imaging background parenchymal enhancement parameters to improve determination of individual breast cancer risk[J]. J Comput Assist Tomogr, 2019，43(1)：85-92.
|
| [21] |
Tagliafico A, Bignotti B, Tagliafico G，et al. Quantitative evaluation of background parenchymal enhancement (BPE) on breast MRI. A feasibility study with a semi-automatic and automatic software compared to observer-based scores[J]. Br J Radiol，2015，88(1056)：20 150 417.
|
| [22] |
Amano Y, Woo J, Amano M, et al. MRI texture analysis of background parenchymal enhancement of the breast[J]. Biomed Res Int，2017，2017：4 845 909.
|
| [23] |
Ha R, Chang P, Mema E, et al. Fully automated convolutional neural network method for quantification of breast MRI fibroglandular tissue and background parenchymal enhancement[J]. J Digit Imaging，2019，32(1)：141-147.
|
| [24] |
Hambly NM, Liberman L, Dershaw DD, et al. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up[J]. AJR Am J Roentgenol，2011，196(1)：218-224.
|
| [25] |
Tomida T, Urikura A, Uematsu T, et al. Contrast enhancement in breast cancer and background mammary-gland tissue during the super-early phase of dynamic breast magnetic resonance tmaging[J]. Acad Radiol，2017，24(11)：1380-1386.
|
| [26] |
Horvat JV, Durando M, Milans S, et al. Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis[J]. Eur Radiol，2018，28(6)：2516-2524.
|
| [27] |
Partridge SC, DeMartini WB, Kurland BF, et al. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value[J]. AJR Am J Roentgenol，2009，193(6)：1716-1722.
|
| [28] |
Plaza MJ, Morris EA, Thakur SB. Diffusion tensor imaging in the normal breast: influences of fibroglandular tissue composition and background parenchymal enhancement[J]. Clin Imaging，2016，40(3)：506-511.
|
| [29] |
Telegrafo M, Rella L, Stabile Ianora AA, et al. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer[J]. Magn Reson Imaging，2016，34(2)：173-176.
|
| [30] |
Grimm LJ, Saha A, Ghate SV, et al. Relationship between background parenchymal enhancement on high-risk screening MRI and future breast cancer risk[J]. Acad Radiol，2019，26(1)：69-75.
|
| [31] |
Mema E, Mango VL, Guo X, et al. Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis[J]. J Magn Reson Imaging，2018，47(3)：753-759.
|
| [32] |
Kohara S, Ishigaki S, Satake H，et al. Background parenchymal enhancement in preoperative breast MRI[J]. Nagoya J Med Sci，2015，77(3)：373-382.
|
| [33] |
Baek JE, Kim SH, Lee AW. Background parenchymal enhancement in breast MRIs of breast cancer patients: impact on tumor size estimation[J]. Eur J Radiol，2014，83(8)：1356-1362.
|
| [34] |
Park SY, Kang DK, Kim TH. Does background parenchymal enhancement on MRI affect the rate of positive resection margin in breast cancer patients？[J]. Br J Radiol，2015，88(1046)：20 140 638.
|
| [35] |
Kim MY, Cho N, Koo HR, et al. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI[J]. Acta Radiol，2013，54(7)：731-738.
|
| [36] |
Preibsch H, Richter V, Bahrs SD, et al. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement[J]. Eur J Radiol，2017，90：181-187.
|
| [37] |
Chen JH, Yu H, Lin M，et al. Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI[J]. Magn Reson Imaging，2013，31(9)：1465-1471.
|
| [38] |
Chen JH, Yu HJ, Hsu C，et al. Background parenchymal enhancement of the contralateral normal nreast: Association with tumor response in breast cancer patients receiving neoadjuvant chemotherapy[J]. Transl Oncol，2015，8(3)：204-209.
|
| [39] |
You C, Gu Y, Peng W, et al. Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer[J]. Acta Radiol，2018，59(7)：806-812.
|
| [40] |
Hilal T, Covington M, Kosiorek HE, et al. Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy[J]. Breast J, 2018，24(6)：1010-1014.
|
| [41] |
Leithner D, Baltzer PA, Magometschnigg HF, et al. Quantitative assessment of breast parenchymal uptake on 18F-FDG PET/CT: Correlation with age, background parenchymal enhancement, and amount of fibroglandular tissue on MRI[J]. J Nucl Med，2016，57(10)：1518-1522.
|